SCHEMBL258462

SCHEMBL258462

c1ccc(N(c2ccccc2)c2ccc(-c3ccc(-c4ccc(N(c5ccccc5)c5ccccc5)cc4)cc3)cc2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.62
TDP1 Q9NUW8 3/20 0.62
L3MBTL1 Q9Y468 2/20 0.62
CYP1A2 P05177 2/20 0.62
CYP3A4 P08684 2/20 0.62
KDM4E B2RXH2 1/20 0.62
CYP2D6 P10635 1/20 0.62
MAPT P10636 1/20 0.62
CYP2C9 P11712 1/20 0.62
CYP2C19 P33261 1/20 0.62
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
CRHBP P24387 1/20 0.50
ATM Q13315 1/20 0.50
CRHR2 Q13324 1/20 0.50
TLR9 Q9NR96 1/20 0.50
APP P05067 2/20 0.46
PKM P14618 1/20 0.44
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9912826 1.00 ALDH1A1 (0.62) ALDH1A1TDP1L3MBTL1CYP1A2CYP3A4
SCHEMBL126831 1.00 ALDH1A1 (0.62) ALDH1A1TDP1L3MBTL1CYP1A2CYP3A4
SCHEMBL17930277 1.00 ALDH1A1 (0.62) ALDH1A1TDP1L3MBTL1CYP1A2CYP3A4
SCHEMBL76699 1.00 ALDH1A1 (0.62) ALDH1A1TDP1L3MBTL1CYP1A2CYP3A4
SCHEMBL12593233 1.00 ALDH1A1 (0.62) ALDH1A1TDP1L3MBTL1CYP1A2CYP3A4
SCHEMBL168018 1.00 ALDH1A1 (0.62) ALDH1A1TDP1L3MBTL1CYP1A2CYP3A4
SCHEMBL12566289 1.00 ALDH1A1 (0.62) ALDH1A1TDP1L3MBTL1CYP1A2CYP3A4
SCHEMBL14621039 1.00 ALDH1A1 (0.62) ALDH1A1TDP1L3MBTL1CYP1A2CYP3A4
SCHEMBL12593212 1.00 ALDH1A1 (0.62) ALDH1A1TDP1L3MBTL1CYP1A2CYP3A4
SCHEMBL9912830 1.00 ALDH1A1 (0.62) ALDH1A1TDP1L3MBTL1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1603 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12048238-B2 Organometallic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2024-07-23 US disclosed
US-12048238-B2 Organometallic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2024-07-23 US disclosed
US-20240244870-A1 LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2024-07-18 US disclosed
US-20240244870-A1 LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2024-07-18 US disclosed
US-20240237391-A1 LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2024-07-11 US disclosed
US-20240237391-A1 LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2024-07-11 US disclosed
US-20240237382-A1 LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2024-07-11 US disclosed
US-20240237382-A1 LIGHT-EMITTING DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2024-07-11 US disclosed
US-12035619-B2 2024-07-09 US disclosed
US-12035621-B2 Light-emitting device and electronic apparatus including the same SAMSUNG DISPLAY CO., LTD. (KR) 2024-07-09 US disclosed
US-20070134573-A1 PHOTORECEPTOR WITH OVERCOAT LAYER XEROX CORPORATION (US) 2007-06-14 US disclosed
US-20070099101-A1 Imaging member XEROX CORPORATION 2007-05-03 US disclosed
US-20070092813-A1 Charge generating layer; first charge transport layer and at least one additional charge transport layer (containing less charge transport material), each of which is a solid solution in a binder and one of which contains a tetraphenylterphenyldiamine; cracking suppression, wear resistance, print quality XEROX CORPORATION 2007-04-26 US disclosed
US-7166397-B2 Imaging members XEROX CORPORATION (US) 2007-01-23 US disclosed
EP-1403325-B1 LIQUID CRYSTAL ORIENTATION AGENTS AND LIQUID CRYSTAL DISPLAY DEVICE WITH THE USE THEREOF NISSAN CHEMICAL IND LTD (JP) 2007-01-03 EP disclosed
EP-0390196-B1 Electrophotosensitive material MITA INDUSTRIAL CO LTD (JP) 1995-09-20 EP disclosed
EP-0385440-B1 Electrophotosensitive material MITA INDUSTRIAL CO LTD (JP) 1995-05-03 EP disclosed
US-5153088-A High sensitivity mixture also with charge transferring substituted phenyl diamines MITA INDUSTRIAL CO., LTD. (JP) 1992-10-06 US disclosed
US-5059503-A Used for copying machine MITA INDUSTRIAL CO., LTD. (JP) 1991-10-22 US disclosed
US-4877702-A PERYLENE TYPE ELECTRIC CHARGE GENERATING SUBSTANCE AND DIAMINE DERIVATIVE AS ELECTRIC CHARGE TRANSFERRING SUBSTANCE MITA INDUSTRIAL CO., LTD. (JP) 1989-10-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12035619-B2 LAGE3, L3MBTL3, L1CAM ALDH1A1 1081/4885TDP1 954/4885L3MBTL1 5/4885
US-12048238-B2 Organometallic compound and organic light-emitting device including the same TRPC1, PPOX, LAGE3 ALDH1A1 654/4885TDP1 42/4885L3MBTL1 18/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.